Audited Financial Results for financial year ended on 31st, March, 2026 along with Auditors report thereon.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Denis Chem Lab reported annual revenue of Rs. 18,172 lakh in FY26, up 4.9% from Rs. 17,330 lakh in FY25. Profit after tax grew 4.1% to Rs. 841 lakh from Rs. 808 lakh. EPS improved marginally from Rs. 5.82 to Rs. 6.06. The Board recommended a final dividend of Rs. 2.50 per share (25%). However, operating cash flow declined sharply to Rs. 413 lakh from Rs. 1,209 lakh in FY25, a drop of about 66%. Trade receivables increased by Rs. 804 lakh while current borrowings rose to Rs. 373 lakh from Rs. 37 lakh. Statutory auditors Shah & Shah Associates gave an unmodified opinion. The company also appointed a new secretarial auditor to fill a vacancy.
The company showed steady but modest growth in revenue and profitability. The sharp decline in operating cash flow and rising receivables/borrowings may signal working capital stress, which could concern investors despite positive PAT growth.